Clinical PET in oncology.
Biersack
H J
HJ
Department of Nuclear Medicine, University of Bonn, PET_Center Bonn.
Bender
H
H
Ruhlmann
J
J
Oehr
P
P
Guhlke
S
S
Grünwald
F
F
D016477:Artifacts; D001786:Blood Glucose / Q000032:analysis; D003299:Cooperative Behavior; D017357:Cyclotrons; D005189:False Positive Reactions; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D005858:Germany; D006801:Humans; D007249:Inflammation / Q000000981:diagnostic imaging; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D008297:Male; D008495:Medical Oncology / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D009367:Neoplasm Staging / Q000379:methods; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D009683:Nuclear Medicine / Q000295:instrumentation / Q000458:organization & administration*; D009928:Organ Specificity; D017410:Practice Guidelines as Topic; D011331:Private Practice / Q000458:organization & administration; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D012680:Sensitivity and Specificity; D014055:Tomography, Emission-Computed / Q000379:methods / Q000706:statistics & numerical data; D014495:Universities / Q000458:organization & administration
D001786:Blood Glucose; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18